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SUMMARY. A simple HPLC method was developed to study the pharmacokinetics of tobramycin in rat
after intravenous administration. The plasma samples were deproteinized with acetonitrile after addition
of the internal standard, netilmicin. The separation was achieved on a reversed-phase C18 column after
derivatization with 9-ﬂuorenylmethyl chloroformate (FMOC-Cl) in borate buffer (0.2 M, pH 6.5) for 15
min at 25 ºC. The mobile phase was water-acetonitrile (6:94, v/v) at a flow rate of 1.0 mL/min. The fluores-
cence excitation and emission wavelengths were 265 and 315 nm, respectively. The method was linear over
the range of 0.12-10.48 μg/mL for tobramycin in plasma. The limit of detection was 0.074 μg/mL. The in-
tra-day and inter-day precisions of tobramycin were both less than 6%. Both derivatives were stable in the
reaction solution for 24 h at room temperature. This assay had been successfully applied to the in vivo ki-
netic study of tobramycin in rats.
